VC and Investment
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Today's issue
Refine Search
Generics
USA-based Impax Laboratories has become the latest company to buy up assets being sold by Israeli generics giant Teva Pharmaceutical Industries in a $586 million deal. 21 June 2016
Generics
India’s Zydus Cadila has added to its US portfolio by buying two new Abbreviated New Drug Applications (ANDAs) from Israeli generics giant Teva Pharmaceutical Industries in an undisclosed transaction. 20 June 2016
Generics
US specialty drugmaker Sagent Pharmaceuticals has agreed to buy five products being developed by Israeli generics giant Teva Pharmaceutical Industries. 17 June 2016
Pharmaceutical
The man brought in to turn around the fortunes of Valeant Pharmaceuticals after a disastrous period for the company, has said that its 1st-qtr financial results reflect the “significant disruption this organization has faced over the past few months.” 8 June 2016
Pharmaceutical
Belgian drug developer Ablynx has raised 74.2 million euros ($82.8) through a private placement of new shares via an accelerated book building procedure announced on Wednesday. 2 June 2016
Pharmaceutical
Leading US shareholder activist Carl Icahn has disclosed that he has acquired a “large position” in Ireland-domiciled Allergan. 1 June 2016
Pharmaceutical
Novartis has expressed confidence that it can achieve long-term sustainable growth despite missing 1st-qtr sales forecasts. 26 May 2016
Pharmaceutical
US-based Ariad Pharmaceuticals will pocket $25 million in second quarter net product revenue related to cumulative shipments of its leukemia treatment Iclusig (ponatinib) to France, following talks with the French health authorities. 20 May 2016
Biotechnology
Danish biotech firm Bavarian Nordic has announced a $100 million contract for its Imvamune smallpox vaccine with a division of the US Department of Health and Human Services. 19 May 2016
Pharmaceutical
German life sciences and pharma company Merck KGaA has increased its first-quarter 2016 sales and earnings following the acquisition of US-based pharma equipment maker Sigma-Aldrich. 19 May 2016
Generics
The assets of Israeli drugmaker Teva Pharmaceutical International in the UK, Ireland and Iceland have attracted interest from bidders including Netherlands-incorporated Mylan and Swiss pharma giant Novartis, Bloomberg reports. 16 May 2016
Biotechnology
Danish biotech firm Genmab recorded a loss of $1.8 million in its 1st-qtr 2016 financial results. 11 May 2016
Pharmaceutical
Japan’s largest drug company, Takeda Pharmaceutical, has recovered from losses the previous year to report increased sales and profits in its financial results for the fiscal year ending in March 2016. 11 May 2016
Pharmaceutical
US drug major Eli Lilly’s Taltz for plaque psoriasis is set to achieve blockbuster status by 2022, an analyst has predicted. 11 May 2016
Biotechnology
A new immune-oncology company with a novel approach to chimeric antigen receptor (CAR) T-cell therapy has been launched by Puretech, it has been announced. 10 May 2016
Biotechnology
US clinical-stage biopharma firm Sorrento Therapeutics has announced that it has engaged financial advisors to explore strategic alternatives to maximize shareholder value. 10 May 2016
Pharmaceutical
Italian drugmaker Recordati has published first quarter 2016 financial results showing revenue was 9.6% higher than it was for the same period in 2015. 5 May 2016
Biotechnology
US biotech Regeneron has raised its revenue estimates for the year due to increased first quarter 2016 sales of its Eylea (aflibercept) injection to treat diabetic retinopathy in patients with diabetic macular edema (DME). 5 May 2016
Pharmaceutical
US pharma giant Pfizer has posted first quarter earnings per share figures which are almost 22% ahead of analysts’ expectations. 3 May 2016
Pharmaceutical
A growth in total revenue driven by selling or out-licensing non-core products could not prevent core operating profit for the first quarter of 2016 to decline at pharma major AstraZeneca. 29 April 2016
Biotechnology
San Francisco, USA-based biotech start-up Kivu Bioscience has announced the closing of a $92 million Series A financing round led by Novo Holdings, which as of year-end 2011123 had total assets of 149 billion euros ($161 billion). 28 October 2024
Biotechnology
Ottimo Pharma, a biotech founded by Medicxi in 2020, has emerged from stealth mode with an executive team packed with prominent industry leaders. 28 October 2024
Biotechnology
Biostar Pharmaceuticals has announced its upcoming initial public offering (IPO) on the Hong Kong Stock Exchange, aiming to raise funds to advance its growing oncology pipeline and support its global expansion efforts. 25 October 2024
Biotechnology
Belgian biotech Agomab Therapeutics today announced a $89 million (82.1 million euros) Series D financing round, with participation from new investors Sanofi and Invus 25 October 2024
Pharmaceutical
Alpha-9 Oncology, a Canadian radiopharmaceutical company, has raised $175 million in an oversubscribed series C financing round led by Lightspeed Venture Partners and Ascenta Capital. 24 October 2024
Biotechnology
US clinical-stage biotech AvenCell Therapeutics announced that it has raised $112 million in Series B financing, which was led by global life sciences investor Novo Holdings. 23 October 2024
Biotechnology
Boston, USA-based Seaport Therapeutics has announced the closing of an oversubscribed $225 million Series B financing round, adding to the $100 million it pulled in along with its launch in April. 21 October 2024
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Biotechnology
LaNova Medicines, a Shanghai-based biopharma company, has announced that it has secured 3 billion yuan ($41 million) in its series C funding round. 18 October 2024
Biotechnology
California, USA-based biotech Terray Therapeutics, yesterday announced the closing of an oversubscribed Series B funding of $120 million. 18 October 2024
Pharmaceutical
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
Pharmaceutical
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
Pharmaceutical
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
Pharmaceutical
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Biotechnology
In Cambridge, UK, the protein specialist Nuclera has raised $75 million in a funding round led by Elevage Medical Technologies and backed by Patient Square Capital. 16 October 2024
Biotechnology
Tolerance Bio has announced the closing of its oversubscribed $17.2 million seed financing round, led by Columbus Venture Partners. 16 October 2024
Biotechnology
In Hong Kong, Akeso Biopharma has successfully raised $250 million through a share placement, marking its second major fundraising effort of 2024. 15 October 2024
Pharmaceutical
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Boston, USA-based Upstream Bio, a biotech developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, has made an impressive start to life as a public-listed company.00000 14 October 2024
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze